Literature DB >> 2218978

Pulmonary disease following intravesical BCG treatment.

S Kesten1, L Title, B Mullen, R Grossman.   

Abstract

Bacillus Calmette-Guérin (BCG) is an attenuated strain of Mycobacterium bovis that has been used in the treatment of malignant disease for over 20 years and for the treatment of bladder cancer since 1976. Major complications of this treatment are infrequent. We report two cases of systemic illness with pulmonary manifestations after treatment with intravesical BCG.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2218978      PMCID： PMC462706          DOI： 10.1136/thx.45.9.709

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  6 in total

1.  Pulmonary complications of intravesical Bacille Calmette-Guérin immunotherapy.

Authors:  D Israel-Biet; A Venet; D Sandron; J M Ziza; J Chretien
Journal:  Am Rev Respir Dis       Date:  1987-03

2.  Systemic complications of intravesical BCG therapy for bladder cancer.

Authors:  A Steg; D Sicard; C Leleu; B Debré; L Boccon-Gibod
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

3.  Bacillus Calmette-Guerin immunotherapy for bladder cancer.

Authors:  D L Lamm
Journal:  J Urol       Date:  1985-07       Impact factor: 7.450

4.  Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors.

Authors:  A Morales; D Eidinger; A W Bruce
Journal:  J Urol       Date:  1976-08       Impact factor: 7.450

5.  Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer.

Authors:  D L Lamm; V D Stogdill; B J Stogdill; R G Crispen
Journal:  J Urol       Date:  1986-02       Impact factor: 7.450

6.  Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma.

Authors:  S A Brosman
Journal:  J Urol       Date:  1982-07       Impact factor: 7.450
  6 in total
  4 in total

1.  Systemic effects of intravesical BCG treatment.

Authors:  B Little; M R A Young; R Convery
Journal:  Ir J Med Sci       Date:  2002 Jul-Sep       Impact factor: 1.568

2.  Pulmonary tuberculosis due to bacille Calmette-Guérin.

Authors:  D Kirsten; U Rieger; K H Schröder; A Böhle; H Magnussen
Journal:  Clin Investig       Date:  1993-10

3.  Bone marrow infection with bacillus Calmette-Guérin (BCG) after intravesical immunotherapy.

Authors:  Johannes Nemeth; Brigitte Stoiser; Heide-Maria Winkler; Leonard Müllauer; Wolfgang Graninger; Stefan Winkler
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 4.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.